Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-21-036355

Chief Scientific Officer sold 30,000 shares at an average $20.16 ($604,706)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lowdell Mark William Chief Scientific Officer 2021-07-07 Sale −5,850 $20.02 $117,117 1,500,401 D: show line 1 in the form
Lowdell Mark William Chief Scientific Officer 2021-07-08 Sale −24,150 $20.19 $487,589 1,476,251 D: show line 2 in the form
Open-market sales · 30,000 sh · avg $20.16 · $604,706
Loading xslF345X03/ownership.xml…